| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/26/2006 | CN1265823C Health-care spray for treating acute injury, chronic strain, rheumatalgia |
| 07/26/2006 | CN1265822C Medicine for treating superficial and deep burn and scald |
| 07/26/2006 | CN1265821C Medicine for treating liver cancer and its preparation method |
| 07/26/2006 | CN1265820C Compound solanum lyratum injection agent for animal |
| 07/26/2006 | CN1265817C Bone injury treating Chinese medicine capsule |
| 07/26/2006 | CN1265815C Kexinkang capsule preparation (for treating cough) and its preparation process |
| 07/26/2006 | CN1265813C Ginseng and aconite capsule for treating qi vacuity and yang depletion and its preparation method |
| 07/26/2006 | CN1265812C Ginseng and aconite powder for injection for treating qi vacuity and yang depletion and its preparation method |
| 07/26/2006 | CN1265811C Ginseng and aconite freeze dried powder for treating qi vacuity and yang depletion |
| 07/26/2006 | CN1265805C Chinese medicine oral preparation for lowering blood sugar and its preparation method |
| 07/26/2006 | CN1265804C Medicine for treating burns and scalds and its preparation |
| 07/26/2006 | CN1265794C Pharmaceutical composition for treating somatization disorder and its preparation process |
| 07/26/2006 | CN1265791C Bergeninum buccal tablets for treating chronic bronchitis and its preparation process |
| 07/26/2006 | CN1265790C Anti-fungal remedy formulation for external application |
| 07/26/2006 | CN1265789C Medicine special for gastric disease |
| 07/26/2006 | CN1265785C Chrono-slow-releasing preparation of hydrochloride verapamil |
| 07/26/2006 | CN1265784C Percutaneous administration preparations |
| 07/26/2006 | CN1265712C Improved anti-inflammatory herbal composition and application method thereof |
| 07/26/2006 | CA2533945A1 Tape preparation |
| 07/25/2006 | US7081525 Crystal forms of azithromycin |
| 07/25/2006 | US7081471 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 07/25/2006 | US7081450 Water insoluble or soluble active compound wrapped with an amphiphilic polymer in a non-crystalline manner toform a nano-sized molecular entity in which no valent bonds are formed |
| 07/25/2006 | US7081267 Nanostructured powders and related nanotechnology |
| 07/25/2006 | US7081256 Quinolinone derivative pharmaceutical compositon and production method therefor |
| 07/25/2006 | US7081255 Antifungal compositions with improved bioavailability |
| 07/25/2006 | US7081254 For relieving or improving skin roughness and suppressing wrinkling, shows neither any offensive smell nor stickiness, gives users a dry feel upon use, and exhibits controlled foaming upon production and stability |
| 07/25/2006 | US7081253 Mixing a membrane-forming molecule, a coemulsifer and a lipophilic agent until a homogeneous clear liquid is obtained, adding the liquid obtained to the water phase of bioactive end formualation without additional enery supply |
| 07/25/2006 | US7081252 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 07/25/2006 | US7081251 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 07/25/2006 | US7081250 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 07/25/2006 | US7081249 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 07/25/2006 | US7081248 A nonaqueous mixture comprising a precursor of vitamins E and A, and vitamin D3 for treating animal |
| 07/25/2006 | US7081247 Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/25/2006 | US7081139 Antimicrobial polyester-containing articles and process for their preparation |
| 07/25/2006 | CA2283133C Pharmaceutical compositions for controlled release of active substances |
| 07/25/2006 | CA2245630C Composition and method for effecting superficial chemical skin peels |
| 07/25/2006 | CA2207652C Hemolysis prevention by surfactants and emulsions |
| 07/25/2006 | CA2186245C Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 07/25/2006 | CA2182812C Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide |
| 07/21/2006 | CA2531983A1 Composite flexible transpirable device formed from separate layers of textile material joined together by a layer of adhesive polymer |
| 07/20/2006 | WO2006076698A1 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 07/20/2006 | WO2006076636A1 Amine polymer-modified nanoparticulate carriers |
| 07/20/2006 | WO2006076533A1 Controlled release compositions comprising an acylanilide |
| 07/20/2006 | WO2006076453A2 METHOD FOR DELIVERING INTERFERON-β |
| 07/20/2006 | WO2006076403A1 Formulations for coated microprojections having controlled solubility |
| 07/20/2006 | WO2006076344A2 Ligand-mediated controlled drug delivery |
| 07/20/2006 | WO2006076338A2 Dosage form for treating gastrointestinal disorders |
| 07/20/2006 | WO2006076277A1 Compositions and methods for increasing the bioavailability of pulmonarily administered insulin |
| 07/20/2006 | WO2006076222A2 Pharmaceutical formulations |
| 07/20/2006 | WO2006076124A2 Stable, non-crystalline formulation comprising olanzapine |
| 07/20/2006 | WO2006076097A2 Stable non-crystalline formulation comprising losartan |
| 07/20/2006 | WO2006075995A2 Article inhibiting microbial growth in physiological fluids |
| 07/20/2006 | WO2006075881A1 Cholanic acid-chitosan complex forming self-aggregates and preparation method thereof |
| 07/20/2006 | WO2006075776A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | WO2006075748A1 Therapeutic agent for allergic conjunctival disease |
| 07/20/2006 | WO2006075690A1 Stable medicinal composition |
| 07/20/2006 | WO2006075502A1 Solid preparation comprising reduced coenzyme q10 and process for production of the same |
| 07/20/2006 | WO2006075125A1 GnRH ANALOGUE FORMULATIONS |
| 07/20/2006 | WO2006075124A1 Somatostatin analogue formulations |
| 07/20/2006 | WO2006075123A1 Topical bioadhesive formulations |
| 07/20/2006 | WO2006074970A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 07/20/2006 | WO2006074546A1 Lipid encapsulated interfering rna |
| 07/20/2006 | WO2006058250A3 Orally disintegrating compositions |
| 07/20/2006 | WO2006058249A9 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 07/20/2006 | WO2006057903A3 Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
| 07/20/2006 | WO2006055142A3 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane |
| 07/20/2006 | WO2006053056A3 Liquid, gas and/or vapor phase delivery systems |
| 07/20/2006 | WO2006050327A3 Lyophilized liposome formulations and method |
| 07/20/2006 | WO2006048895B1 Aqueous pharmaceutical coating |
| 07/20/2006 | WO2006042135A3 Flavored gelatin capsule and method of producing said capsule |
| 07/20/2006 | WO2006038226B1 Process for making a highly compressible controlled delivery compositions of metformin |
| 07/20/2006 | WO2006037342A3 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/20/2006 | WO2006029845A3 Delivery vehicle containing nanoparticles |
| 07/20/2006 | WO2006012541A3 Compositions and methods for treating excessive bleeding |
| 07/20/2006 | WO2006006021A3 Stabilized pharmaceutical compositions of preferably a statin |
| 07/20/2006 | WO2005123033A3 Fine particles of cilostazol and processes for production thereof |
| 07/20/2006 | WO2005115318A3 Method for thickening hair and hair thickener |
| 07/20/2006 | WO2005107721A3 Pharmaceutical dosage form comprising pellets as well as its manufacturing process |
| 07/20/2006 | WO2005102270A3 Agent-releasing system comprising an agent-containing patch and at least one means regulating the release of agents |
| 07/20/2006 | WO2005074353A8 Sterile in-situ microcarrier forming gelled polymeric dispersions and processes to manufacture the same |
| 07/20/2006 | WO2005072704A3 Method of treating acute rhinosinusitis |
| 07/20/2006 | WO2005053640A3 Azithromycin multiparticulate dosage forms by liquid-based processes |
| 07/20/2006 | WO2005039668A3 Implantable drug delivery device for sustained release of therapeutic agent |
| 07/20/2006 | WO2004080413A3 Uses and formulations for transdermal or transmucosal application of active agents |
| 07/20/2006 | WO2004073765A3 Drug delivery device and syringe for filling the same |
| 07/20/2006 | WO2003084467A3 Epitope constructs comprising antigen presenting cell targeting mechanisms |
| 07/20/2006 | US20060161183 Instrument for assisting in the remote placement of tied surgical knots and trimming of suture away from the knot and method of use |
| 07/20/2006 | US20060160946 Polymeric dispersant having an affinity with a supercritical fluid |
| 07/20/2006 | US20060160918 Curable compositions |
| 07/20/2006 | US20060160900 Intrathecal Gabapentin for Treatment of Pain |
| 07/20/2006 | US20060160899 Delivering gabapentin to the cerebrospinal fluid or brain using a pump system |
| 07/20/2006 | US20060160745 Agents for preventing postoperative recurrence of premenopausal breast cancer |
| 07/20/2006 | US20060160739 GRF-containing lyophilized pharmaceutical compositions |
| 07/20/2006 | US20060160722 Administering glucagon daily as part of a diabetes treatment regimen |
| 07/20/2006 | US20060159776 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases |
| 07/20/2006 | US20060159769 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 07/20/2006 | US20060159768 Quetiapine granules |
| 07/20/2006 | US20060159767 Nanoparticulate bicalutamide formulations |
| 07/20/2006 | US20060159766 Nanoparticulate tacrolimus formulations |